Tue, Jul 22, 2014, 5:01 AM EDT - U.S. Markets open in 4 hrs 29 mins

Recent

% | $
Click the to save as a favorite.

Atlas Air Worldwide Holdings Inc. Message Board

rrtzrealmd 93 posts  |  Last Activity: 8 hours ago Member since: Aug 24, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • rrtzrealmd rrtzrealmd 8 hours ago Flag

    "Institutionals...are not selling."? How do you know? Judging from the chart, SOMEBODY is certainly selling.

  • Reply to

    Dr. Mann's Age is a Non Issue

    by akemp3000 8 hours ago
    rrtzrealmd rrtzrealmd 8 hours ago Flag

    ...well, actually it is...the day he kneels over the stock'll probably jump 25%...

  • Reply to

    regarding patent.. rrtzrealmd..

    by triple2sss1 Jul 18, 2014 3:25 PM
    rrtzrealmd rrtzrealmd 19 hours ago Flag

    ...:"fda granted exclusive marketing rights"???...what on earth are you talking about?...since when did the FDA start granting "exclusive marketing rights" for medical devices?...no, the FDA grants approval for marketing of medical devices -- okay?...something which Sandoz and ihealth both ALREADY HAVE, but which dario -- the last time I looked -- DOESN'T...

    ...and, no, the FDA could care less about patent infringement...what has any of this got to to do with DRIO?...

    ...are you so desperate for an argument to buy the stock that you're trying to argue the potential value of future claims for infringement on a patent that's pending?...well, that's a new one on me...I think I would wait until DRIO management offers some insight about how THEY view any patent issues...

    ...I notice that even though the ihealth device has been on the market for two months now and looks remarkably like dario, DRIO's management hasn't offered any commentary about how it affects the company's prospects -- especially the issue of those 75% CHEAPER ihealth strips...do they think maybe if they ignore it, it'll just go away?...

  • rrtzrealmd rrtzrealmd 19 hours ago Flag

    "will these people will rather choose dario or CGM"?...that's easy !...NEITHER!...they'll choose the ihealth device because the strips cost 75% LESS than dario's...not to mention the added COST of the special lancets that are required for the dario...

    ...and I was pointing to CGM primarily as yet one more example of how ANTIQUE the dario is...the thing is practically moldy!...

  • rrtzrealmd by rrtzrealmd Jul 19, 2014 1:31 PM Flag

    Looking at some of the comments on youtube dario videos, one lady said, "what an absolute nightmare if you forget your phone!" Amen to that!

    Someone else pointed out how you not only have to use dario test strips, but lancets as well, since they're designed specicifically to work with that case an added expense?

    I'm not seeing a lot of enthusiasm for dario, ya'know?

    Someone else also put up a video about Google's contact lens glucose monitor -- cool!

    I'm telling you, dario's so antiquated it's a wonder that DRIO is actually trying to sell the thing. Of course, if they didn't try, they wouldn't have any reason to sell stock, would they?

  • Reply to

    regarding patent.. rrtzrealmd..

    by triple2sss1 Jul 18, 2014 3:25 PM
    rrtzrealmd rrtzrealmd Jul 19, 2014 1:14 PM Flag

    ..."seem like u dont understand" that ihealth is ALREADY approved and ALREADY on the market...if DRIO's got a worthwhile patent, then one might reasonably expect them to speak up and say so...but have they done that?...nowhere that I can find...so while YOU are sitting around WAITING for dario's patent application and WAITING for dario's FDA approval, ihealth is going to be out HAMMERING the market with its test strips that cost ONE QUARTER of the price of most other strips...have fun!...

  • rrtzrealmd by rrtzrealmd Jul 18, 2014 7:40 PM Flag

    I saw a PR announcing someoen named "Mikael Salo" had been appointed "Veteran Sales Manager for Scandinavia."...ostensibly he was "to establish new Nordic headquarters in Helsinki"...

    ...then I looked at his linkedin page where it says that his current employment is:

    "Counselor for intellectually disabled children and youth at Esperi Oy Narikka
    Founder and Manager at LinkedIn's Olympus Alumni Group"

    ...it then says his PAST employment included:

    "Managing Director, Nordic Countries at Labstyle Innovations- Dario June 2013 – December 2013 (7 months) Helsinki, Finland"

    ...so he went from being "managing director" for Nordic distribution of darios to being a "counselor for intellectually disabled children"...I dunno but somehow that just seems so...sooo...soooooo...APPROPRIATE!...HAW!...he shoulda got a job counseling "intellectuallly disabled" biotech investors -- he woulda been FLOODED with customers!...HAW!...

    ...in any case, since DRIO doesn't appear to have replaced him, can investors assume its "ixnay" on the Helsinki headquarters and that they've written off the "Nordic" market?....

  • Reply to

    regarding patent.. rrtzrealmd..

    by triple2sss1 Jul 18, 2014 3:25 PM
    rrtzrealmd rrtzrealmd Jul 18, 2014 7:10 PM Flag

    ...all I know is that ihealth's device looks like dario, is already FDA approved and is already on the market...that was since about 1-2 months ago...since then I haven't seen any comments from DRIO about any patent issues...since that device obviously humilates dario -- and practically every other glucometer if the price of a strip actually is only about 20 cents each -- then I would presume Labstyle management knows about it...Labstyle's failure to comment seems pretty obviously a declaration of no patent infringement...that, in turn, means Labstyle's patents are worth about as much as Labstyle itsef -- i.e. ZERO.

  • Reply to

    rrtzrealmd.. seek for your advice

    by triple2sss1 Jul 18, 2014 3:50 PM
    rrtzrealmd rrtzrealmd Jul 18, 2014 7:00 PM Flag

    "...labstyle is one of the worst company in the world?"...oh, definitely!...it and ORMP and a several other Israeli companies that I've stumbled across recently are definitely vying for "Stinkin' Heap of Fresh Dog Manure" award...

    ..."very good result of dario soft launch"???...what very good "result"?...per the 10Q for quarter ending in March, revenues were ZERO, and I haven't seen them announce any revenue or profit projections...and none of the announcements about distrbutor deals mentions any actual silver crossing palms...until I see 10Qs with REAL numbers on them, announcements about distributors or reimbursement approvals are just smoke and mirrors designed to sell stock to naive investors...

    ...as far as I'm concerned, the thing is antiquated compared to what's already available, offers stuff that diabetics don't care about, isn't cost competitive according to the numbers presented on some of the distributors websites, etc, etc...

    ...cap all that by by the fact that continuous glucose monitoring is the next "big thing"...even AAPL is working on a non-invasive one...the Chinese are bringing one to market...and Medtronic now offers a combination CGM/insulin pump...etc, etc...

    ...dario is ancient history...it actually went out of business maybe five years ago, but just hasn't realized it -- kinda like buggy whip manufacturers a century ago...or more likely Labstyle did realize it and that's why they decided to do an IPO before everyone else figured it out as well...

  • Reply to

    A "toxic" private placement?

    by rrtzrealmd Jul 17, 2014 2:05 AM
    rrtzrealmd rrtzrealmd Jul 18, 2014 9:30 AM Flag

    ...here's the rest:

    "A registration statement registering only the Shares and the Warrants Shares for public resale was declared effective on June 3, 2014, thus triggering the commencement of the Adjustment Period. In accordance with the Securities Purchase Agreement, because the Adjustment Price ($0.89, as calculated above) was less than the price per share in the Offering ($1.88), on July 3, 2014, the Company issued an aggregate of 2,484,416 unregistered Adjustment Shares to the Buyers. In addition, pursuant to the terms of the Warrants and as a result of the issuance of the Adjustment Shares, the exercise price of the Warrants was reduced to $0.89 per share and the number of Warrant Shares was increased by an aggregate of 2,746,688 shares of Common Stock (the “Additional Warrant Shares”). Since the Adjustment Shares were not freely tradable when issued, the Company may be required to issue further additional Adjustment Shares if the Adjustment Price is less than $0.89 per share following a second Adjustment Period which will commence on the earlier to occur of August 18, 2014 or the date when a registration statement covering the resale of the Adjustment Shares and Additional Warrant Shares is declared effective by the SEC."

    The only thing I see that I may have misinterpreted was that for the upcoming adjustment period, the stock needs to stay above 89 CENTS in order to avoid having to issue more FREE stock and MORE free warrants.

    Still translates into potentially INFINITE dilution as long as the stock keeps dropping.

  • Reply to

    A "toxic" private placement?

    by rrtzrealmd Jul 17, 2014 2:05 AM
    rrtzrealmd rrtzrealmd Jul 18, 2014 9:25 AM Flag

    "Somewhat more"??? Well, if you wanted the whole thing you could've just said so...here's the first part:

    "On February 12, 2014, LabStyle Innovations Corp...entered into a definitive Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional and accredited investors (the “Buyers”) to raise approximately $4.19 million in gross proceeds in a private placement offering (the “Offering”) of consisting of an aggregate of (i) 2,226,956 shares (the “Shares”) of the Company’s common stock (the “Common Stock”) and warrants (the “Warrants”) to purchase an aggregate of 1,670,216 shares of Common Stock (the “Warrant Shares”). The Offering closed on February 18, 2014.

    Pursuant to the terms of the Securities Purchase Agreement, the Company is potentially required to issue additional shares of Common Stock (the “Adjustment Shares”) at a specified time to the Buyers in the event that the price per share of Common Stock in the Offering ($1.88) is greater than the price per share of the Common Stock, calculated as 90% of the average of the ten (10) lowest volume weighted prices of the Common Stock (the “Adjustment Price”) during the twenty (20) trading day period (the “Adjustment Period”) starting immediately following the earlier of the date on which the Shares, Warrants Shares and Adjustment Shares have been registered for resale with the Securities and Exchange Commission (“SEC”) or are able to be sold without restriction under Rule 144 under the Securities Act, of 1933, as amended; provided, that, subject to the terms and conditions of the Securities Purchase Agreement, the Company may be required to issue further additional Adjustment Shares at one or more additional specified times if the Adjustment Shares are not freely tradable for certain specified minimum periods."

  • Reply to

    A "toxic" private placement?

    by rrtzrealmd Jul 17, 2014 2:05 AM
    rrtzrealmd rrtzrealmd Jul 17, 2014 12:08 PM Flag

    "raise a modest amount of additional money"???...uhhh, hello!...did you read it?...they GAVE AWAY 2.5 MILLION shares of stock AND they also GAVE AWAY 2.5 MILLION warrants AND they reduced the warrant exercise price to 89 CENTS...DRIO did not collect ONE DIME in the transaction...

    ...NOT ONLY THAT, but DRIO will have to repeat this process OVER AND OVER as long as the stock price is below $1.88...in other words there is potentially INFINITE dilution!...somehow I don't think INFINITE DILUTION has been "factored" into the stock price...

  • From the July 10 8-K:

    "On February 12, 2014, LabStyle Innovations Corp...entered into a definitive Securities Purchase Agreement...to raise approximately $4.19 million...in a private placement offering...2,226,956 shares...and warrants... to purchase an aggregate of 1,670,216 shares of Common Stock...

    ...the Company is potentially required to issue additional shares...to the Buyers in the event that the price per share...in the Offering ($1.88) is greater than the price per share of the Common Stock, calculated as 90% of the average of the ten (10) lowest volume weighted prices of the Common Stock ...during the twenty (20) trading day period...starting immediately following the earlier of the date on which the Shares, Warrants Shares and Adjustment Shares have been registered for resale with the Securities and Exchange Commission (“SEC”) or are able to be sold without restriction...

    ...A registration statement was declared effective on June 3, 2014...because the Adjustment Price ($0.89, as calculated above) was less than the price per share in the Offering ($1.88), on July 3, 2014, the Company issued an aggregate of 2,484,416 unregistered Adjustment Shares... the exercise price of the Warrants was reduced to $0.89 per share and the number of Warrant Shares was increased by an aggregate of 2,746,688 shares..."

    And apparently this can go on ad infinitum as long as the stock price keeps falling! Well, issuing 5 million shares is likely to help it go up, is it?

  • rrtzrealmd by rrtzrealmd Jul 17, 2014 1:47 AM Flag

    Someone posted ealier about Kaplan being nrought on board for "his expertise in clinical trials data management"...yeah, right!...but I guess it's just a coincidence that both Fuerst and Kaplan are on the "executive team" of Medivizor -- a company that seeks to "Improve the lives of people with serious or chronic medical conditions and of those who care for them"...and get stinkin' rich while doing it -- right?...Fuerst is the "chairman," and Kaplan is the "chief medical officer"...so when's the IPO I wonder!

    ...in any case, most likely Fuerst brought Kaplan on just to give his "buddy" a spot at the shareholder equity "trough"...not to mention, it no doubt helps reduce the likelihood of dissension by anyone looking to force the company to actually do something for shareholders!...

  • rrtzrealmd by rrtzrealmd Jul 16, 2014 11:50 PM Flag

    "This prospectus relates to the offering and resale by the selling stockholders identified herein of up to 20,982,902 shares of our common stock, par value $0.0001 per share. These shares were privately issued to the selling stockholders on August 29, 2013 in exchange for shares of Intra-Cellular Therapies, Inc., a Delaware corporation, which is now our wholly-owned subsidiary and which has assumed the name ITI, Inc. We will not receive any proceeds from the sale of these shares by the selling stockholders."

    I am soooooooooooooo surprised!...HAW!...

  • Reply to

    this company sure is quiet,

    by johnnybgood270 Jul 15, 2014 7:10 PM
    rrtzrealmd rrtzrealmd Jul 15, 2014 7:56 PM Flag

    ..."Guess their working real hard?"????...oh, wait a minute!!...I can't let that go by!......hold on a second!.........gotta pull myself together!...okay, okay!!...here it is:

    HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW, HAW!!!!!!!

    ...aw, man!...looks like I gotta run and change my depends!!...HAW!

  • Reply to

    Gag me with some...

    by rrtzrealmd Jul 15, 2014 12:05 PM
    rrtzrealmd rrtzrealmd Jul 15, 2014 7:28 PM Flag

    ...uhhhh...his name to help add credibility to a scam, maybe?...and a really, really awful hairstyle (judging from his Iris Cantor photo)...that's about all I can think of...unless, of course, the company is thinking about developing a little urinanalyis box complete with test stips...and in exchange he gets to collect a nice fat quarterly fee for picking up the telephone and "attending" a BOD meeting for an hour or so...easy money to help pay for that ritzy home in Chappaqua...

  • rrtzrealmd by rrtzrealmd Jul 15, 2014 12:05 PM Flag

    ...three day old roadkill already!...fom an interview with the CEO:

    "July 3, 2014 6:08 am

    Three months after his father died of diabetes,...Rafael received an offer to join Lifestyle.. "Like someone radioed me to come work here," he said in an interview with G and hoped that investors lined up with the development that could change the lives of 350 million diabetics worldwide..."

    "Radioed him"???....sheeez!...did they also "radio" him that million bucks they paid him in 2013?...

    ...I mean, seriously, look at this guy's work history:

    1998-2011 Amdocs in order: software engineer, development manager - amdocs delivery Group, post-merger Integration & program manager, director of strategy - CTO Office

    2010-2012 Co-founder: redB -- "LTD introduced mySuper.co.il as an e-commerce platform for supermarkets..." which apparently went belly-up since "redb" is now some sort of streaming video service.

    I wonder whether it wasn't the the unemployment office that "radioed" him!

    So his experience with diabetes is limited to his dad, his experience with medical devices in general is nil, as evidently is his experience with marketing, but if we need someone to fix the computer, he's the guy to call -- is that about right?

    And they paid him a million in 2013??? Go figure!

  • rrtzrealmd by rrtzrealmd Jul 14, 2014 8:29 PM Flag

    ...starting a new thread since yahoo gets messy after a half dozen or so responses...

    ...in any case, from 2 years ago:

    "Philosys announced today that it has received the CE Mark for the Gmate SMART Blood Glucose Monitoringblood glucose monitoring Sugar monitoring Lab medicine."

    Now if you go to their website , you can see:

    ___.imsol-inc.___/product/gmate-smart/

    ...sorry, but thanks to yahoo's dislike of hotlinking, you'll have to fill in the blanks yourself...as you can see, it bears a rather striking remsemblance to you know who...now, in 2011, at least, they were claiming:

    "The patent pending technology of the Gmate SMART uses the operating system of the smart phone and works by plugging the device into the headphone See headphones. connector of the smart phone, and launching the companion app."

    ...and that's where I stopped...someone else can go look to see if there might be any patent infringement issues...

  • Reply to

    And speaking of convenience...

    by rrtzrealmd Jul 11, 2014 1:35 PM
    rrtzrealmd rrtzrealmd Jul 14, 2014 6:47 PM Flag

    I looked for "labstyle" and found only those two items...I looked up some of the indiviuals and under "feurst" found one more: "CLAIM The ornamental design for a blood glucose cartridge, as shown and described."...but all it shows is a drawing of the other two drawings combined into one-- " FIG. 1 is a perspective view of a blood glucose cartridge showing our new design" plus drawings from above, below, etc...it's listed as: "Filed on Jan. 24, 2013, as Appl. No. 29/443,968."...so it looks to me that all they have patented in the US is the design of the box and of the phone plug...

    I also looked for "dario" and found a bunch of people but nothing related to "dario" -- have they even bothered to trademark the name?

AAWW
35.69-0.37(-1.03%)Jul 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.